The Future of Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

The Future of Clinical Trials in Brazil

The Future of Clinical Trials in Brazil – Biotech Clinical Trials

Clinical trials play a pivotal role in advancing medical research, improving patient care, and driving healthcare innovation. In recent years, Brazil has emerged as a leading destination for conducting clinical trials.

With a robust healthcare system, a diverse population, and supportive regulatory reforms, Brazil holds immense potential for shaping the future of clinical trials. This blog explores the current landscape of clinical trials in Brazil, highlighting the advancements, opportunities, and challenges that lie ahead.

Regulatory Reforms and Streamlined Processes


Brazil has implemented significant regulatory reforms to enhance the efficiency and transparency of clinical trials. The National Health Surveillance Agency (ANVISA) oversees clinical trial regulations, ensuring participant safety and data integrity.


Reforms have streamlined approval processes, reduced bureaucratic hurdles, and provided clearer guidelines, making Brazil an attractive destination for clinical research. These reforms have also fostered international collaborations and increased the country’s competitiveness in the global clinical trial landscape.


Expansion into Diverse Therapeutic Areas


Brazil’s clinical trial landscape has expanded beyond traditional therapeutic areas, such as infectious diseases, to encompass a wide range of specialties. The country has become a hub for research in oncology, cardiology, neurology, and other medical fields.


This diversification not only benefits local patients by providing access to innovative treatments but also contributes to global scientific knowledge and therapeutic advancements. The diverse patient population in Brazil allows for more inclusive and representative clinical trials, resulting in more accurate and generalizable study outcomes.


Collaborations and Partnerships


Collaborations between Brazilian research institutions, pharmaceutical companies, and international organizations have been instrumental in advancing clinical trials in the country. These partnerships facilitate knowledge exchange, resource-sharing, and capacity building, driving the quality and impact of clinical research.


Collaborative efforts bring together diverse expertise, promote interdisciplinary approaches, and foster innovation. Such collaborations also contribute to the local research ecosystem, bolstering infrastructure, and expertise, while enhancing Brazil’s position as a global player in clinical trials.


Technological Advancements and Digital Transformation


The future of clinical trials in Brazil is intertwined with technological advancements and digital transformation. From electronic data capture systems to telemedicine and remote monitoring, technology is revolutionizing the way clinical trials are conducted.


These innovations improve data accuracy, enhance patient engagement, and enable real-time data analysis, leading to more efficient and cost-effective trials. Brazil’s increasing adoption of technology, the widespread availability of internet connectivity, and the rising digital literacy among the population create a fertile ground for the integration of these advancements.


The Future of Clinical Trials in Brazil

The Future of Clinical Trials in Brazil

The Future of Clinical Trials in Brazil

Patient-Centric Approaches and Real-World Data


The future of clinical trials in Brazil will prioritize patient-centric approaches and the integration of real-world data. Emphasizing patient engagement, patient-reported outcomes, and shared decision-making will ensure that trials are aligned with patients’ needs and preferences.


Additionally, the integration of real-world data collected from routine clinical practice will provide a more comprehensive understanding of treatment effectiveness, safety, and long-term outcomes. This approach will not only improve patient care but also enhance the efficiency and relevance of clinical trials in Brazil.


Addressing Challenges and Ensuring Quality


While Brazil has made significant progress in clinical trials, challenges remain. Ensuring quality and maintaining high ethical standards are paramount. Continued investment in training programs for investigators and research staff, adherence to Good Clinical Practice (GCP) guidelines, and robust regulatory oversight are crucial for maintaining participant safety, data integrity, and the credibility of clinical research in Brazil.


Collaboration between regulatory bodies, sponsors, and research institutions is essential to promote transparency, strengthen quality assurance measures, and foster a culture of continuous improvement.


Public Awareness and Community Engagement

Public awareness and community engagement are essential for the future of clinical trials in Brazil. Educating the public about the importance of clinical research, its benefits, and the rights of participants will help build trust and dispel misconceptions.

Engaging with communities to understand their needs, perspectives, and cultural nuances will ensure that trials are designed with their best interests in mind. Collaborative efforts between research institutions, healthcare providers, and patient advocacy groups can help disseminate accurate information, address concerns, and encourage participation in clinical trials.

By fostering open dialogue and involving patients and the public in the research process, Brazil can create a more inclusive and patient-centered clinical trial ecosystem.


Brazil is poised to shape the future of clinical trials, leveraging its robust healthcare system, diverse patient population, regulatory reforms, and technological advancements. With streamlined processes, collaborations, and patient-centric approaches, Brazil has the potential to attract more international trials, drive innovation, and contribute significantly to medical research and healthcare advancements.

By addressing challenges, ensuring quality, promoting public awareness, and engaging communities, Brazil can unlock the full potential of clinical trials, leading to improved patient care, expanded treatment options, and a brighter future for healthcare in the country.

The Future of Clinical Trials in Brazil

Source: Duke Clinical Research Institute

The Future of Clinical Trials in Brazil

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

The Future of Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
The Future of Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

The Future of Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

The Future of Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

The Future of Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

The Future of Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
The Future of Clinical Trials in Brazil

The Cohortias Team

The Future of Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

The Future of Clinical Trials in Brazil

Network & Partnerships